(Q45984720)
Statements
1 reference
A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye. (English)
1 reference
Shigeru Kinoshita
1 reference
Saki Awamura
1 reference
Norihiro Nakamichi
1 reference
Hiroyuki Suzuki
1 reference
Kazuhide Oshiden
1 reference
Norihiko Yokoi
1 reference
Rebamipide Ophthalmic Suspension Long-term Study Group
1 reference
16 November 2013
1 reference
157
1 reference
3
1 reference
576-83.e1
1 reference